The International Olympic Committee (IOC) Consensus Statement on Periodic Health Evaluation of Elite Athletes, March 2009
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
INTRODUCTION The Olympic Games is the largest sport event in the world. In Beijing, 10,500 athletes competed, selected from a large group of elite athletes in 204 countries. Sports participation on the elite level, aside from winning medals, fame and other rewards, is also important from a health perspective. There is no longer any doubt that regular physical activity reduces the risk of premature mortality in general, and of coronary heart disease, hypertension, colon cancer, obesity, and diabetes mellitus in particular. The question is whether the health benefits of sports participation outweigh the risk of injury and long-term disability, especially in high-level athletes.1 have studied the incidence of chronic disease and life expectancy of former male world-class athletes from Finland in endurance sports, power sports and team sports. The overall life expectancy was longer in the high-level athlete compared to a reference group (75.6 vs 69.9 years). The same group also showed that the rate of hospitalization later in life was lower for endurance sports and power sports compared to the reference group.2 This resulted from a lower rate of hospital care for heart disease, respiratory disease and cancer. However, the athletes were more likely to have been hospitalized for musculoskeletal disorders. Thus, the evidence suggests that although there is a general health benefit from sports participation, injuries represent a significant side effect. One priority of the International Olympic Committee (IOC) is to protect the health of the athlete. During recent years, prevention of injuries and illnesses has been high on the IOC agenda. During the Athens Games an injury surveillance system was applied for all team sports.3 During the Beijing Games, the IOC ran, for the first time, an injury surveillance system covering all the athletes, showing a 10% incidence of injuries.4 In Vancouver and London the surveillance system will include disease conditions as well. The surveillance studies are prerequisites for providing evidence for health development in sports as well as for developing prevention programs. Another method to decrease injuries and diseases in the elite athlete is to perform a pre-participation examination (PPE) or periodic health evaluation (PHE) of all elite athletes.5 PHE in various forms have been available for many years, but a recent analyses5 has questioned the efficacy of PHEs in detecting serious problems in the elite athlete. In March 2009, the IOC assembled an expert group to discuss the current state of health evaluations for athletes, aiming to provide recommendations for a practical PHE for the elite athlete, as well as to outline the need for further research. The task of the group was to review the benefits as well as potential negative effects of PHE at the elite sport level. The group did not take any position as to whether PHE should be recommended as compulsory for participation in sport. That is for the relevant sports authorities to decide. The PHE can serve many purposes. It includes a comprehensive assessment of the athlete's current health status and risk of future injury or disease and, typically, is the entry point for medical care of the athlete. The PHE also serves as a tool for continuous health monitoring in athletes. Recent advances in this field relate to: (1) data on sudden cardiac death and other noncardiac medical problems, and the detection of risk factors and groups; (2) a consensus conference on concussion; (3) data on eating disorders; and (4) data on risk factors for musculoskeletal injuries. This paper addresses each of these advances in more detail after a discussion on the purpose of a PHE and the evidence we have supporting the different components of the PHE. PURPOSES OF THE MEDICAL EVALUATION In a narrow sense, the main purpose of the PHE is to screen for injuries or medical conditions that may place an athlete at risk for safe participation. Athletes may be affected by conditions that do not have overt symptoms and that can only be detected by periodic health evaluations. One example is cardiovascular abnormalities, such as hypertrophic cardiomyopathy, arrythmogenic right ventricular cardiomyopathy or congenital coronary arteries anomalies. These are typically silent until a potentially fatal arrhythmia occurs, but may in some cases be detected through a careful cardiovascular examination. Screening is a strategy used in a population to detect a disease in individuals without signs or symptoms of that disease. The intention is to identify pathologic conditions early, thus enabling earlier intervention and management in the hope of reducing future morbidity and mortality. Although screening may lead to an earlier diagnosis, not all screening programs have been shown to benefit the person being screened. To ensure that screening programs confer the intended benefit, the World Health Organisation published what have become known as the Wilson-Jungner crite
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Corrado, D., Basso, C., Pavei, A., Michieli, P., Schiavon, M., & Thiene, G. (2006) · JAMA · doi:10.1001/jama.296.13.1593 · Cited by 1,559
The SCOFF questionnaire: Assessment of a new screening tool for eating disorders
Morgan, J. F., Reid, F., & Lacey, J. H. (1999) · BMJ · doi:10.1136/bmj.319.7223.1467 · Cited by 1,416
Sudden Death in Young Athletes
Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022783 · Cited by 1,394 · cited 1×
“The vast majority of the athletes dying suddenly do not experience premonitory symptoms (9); therefore, the PHE represents the only strategy capable to identify athletes with silent cardiac disease, and allow appropriate management to reduce the risk of SCD and disease progression.”
BackgroundDoes sports activity enhance the risk of sudden death in adolescents and young adults?
Corrado, D., Basso, C., Rizzoli, G., Schiavon, M., & Thiene, G. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.03.002 · Cited by 1,311 · cited 2×
“The relative risk of sport participation is different according to the underlying disease, and it is greatest in case of cardiomyopathies (such as hypertrophic cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy) or congenital coronary arteries anomalies (Corrado et al 2003).”
BackgroundThompson (2007) · doi:10.1161/circulationaha.107.181485 · Cited by 1,000
Pelliccia, A. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi325 · Cited by 983
Self-citationAge at menarche and racial comparisons in US girls
Chumlea, W. C., Schubert, C. M., Roche, A. F., Kulin, H. E., Lee, P. A., Himes, J. H., & Sun, S. S. (2003) · PEDIATRICS · doi:10.1542/peds.111.1.110 · Cited by 685
Maron, B. J., & Zipes, D. P. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.006 · Cited by 616
Eating disorder examination questionnaire: norms for young adolescent girls
Carter, J. C., Stewart, D. A., & Fairburn, C. G. (2001) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(00)00033-4 · Cited by 379
Increased life expectancy of world class male athletes.
SARNA, S., SAHI, T., KOSKENVUO, M., & KAPRIO, J. (1993) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199302000-00013 · Cited by 347
Athletic induced iron deficiency: new insights into the role of inflammation, cytokines and hormones
Peeling, P., Dawson, B., Goodman, C., Landers, G., & Trinder, D. (2008) · European Journal of Applied Physiology · doi:10.1007/s00421-008-0726-6 · Cited by 292 · cited 1×
“In addition, iron deficiency anemia is more common in the female athlete (101).”
BackgroundDisorders of the Female Athlete Triad Among Collegiate Athletes
Beals, K. A., & Manore, M. M. (2002) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.12.3.281 · Cited by 240 · cited 1×
“The incidence of primary amenorrhea is 22% in cheerleading, diving and gymnastics (109) in comparison to <1% in the general population (110).”
BackgroundInfectious episodes before and after a marathon race
Ekblom, B., Ekblom, Ö., & Malm, C. (2006) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/j.1600-0838.2005.00490.x · Cited by 88 · cited 2×
“Firstly, it is established that during intense training and immediately following competitions, there is evidence of immune suppression in athletes that could predispose them to infective disease (59,60).”
Background
Cited by
Energy Availability in Athletics: Health, Performance, and Physique
Melin, A. K., Heikura, I. A., Tenforde, A., & Mountjoy, M. (2019) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.2018-0201 · Cited by 258
Self-citationGalderisi, M., Cardim, N., D'Andrea, A., Bruder, O., Cosyns, B., Davin, L., Donal, E., Edvardsen, T., Freitas, A., Habib, G., et al. (2015) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu323 · Cited by 258
Daily iron supplementation for improving anaemia, iron status and health in menstruating women
Low, M. S. Y., Speedy, J., Styles, C. E., De-Regil, L. M., & Pasricha, S.-R. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009747.pub2 · Cited by 178
Prevention of eating disorders in female athletes
Coelho, G., de Abreu Soares, E., Innocencio da Silva Gomes, A., & Goncalves Ribeiro, B. (2014) · Open Access Journal of Sports Medicine · doi:10.2147/oajsm.s36528 · Cited by 96
Metadata
- Authors
- Ljungqvist, A., Jenoure, P. J., Engebretsen, L., Alonso, J. M., Bahr, R., Clough, A. F., de Bondt, G., Dvorak, J., Maloley, R., Matheson, G., Meeuwisse, W., Meijboom, E. J., Mountjoy, M., Pelliccia, A., Schwellnus, M., Sprumont, D., Schamasch, P., Gauthier, J.-B., & Dubi, C.
- Venue
- Clinical Journal of Sport Medicine
- Published
- 2009-09
- Volume
- 19
- Issue
- 5
- Pages
- 347-365
- ISSN
- 1050-642X (ISSN-L)
- OpenAlex
- W2137762272
- Cited by
- 138
- References
- 13
- FWCI
- 5.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.